3M Company (MMM) - Q3 2008 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended September 30, 2008. 3M is a diversified global manufacturer operating in six segments: Industrial and Transportation, Health Care, Display and Graphics, Consumer and Office, Safety, Security and Protection Services, and Electro and Communications. The company reorganized its business segments effective in the first quarter of 2008. Results reflect a challenging global economic environment, particularly in the U.S. retail, automotive, and housing sectors, alongside high commodity prices.
Key Financial Metrics
| Metric | Q3 2008 | Q3 2007 | 9M 2008 | 9M 2007 |
|---|---|---|---|---|
| Net Sales | $6,558 million | $6,177 million | $19,760 million | $18,256 million |
| Operating Income | $1,513 million | $1,425 million | $4,463 million | $4,923 million |
| Operating Margin | 23.1% | 23.1% | 22.6% | 27.0% |
| Net Income | $991 million | $960 million | $2,924 million | $3,245 million |
| Diluted EPS | $1.41 | $1.32 | $4.11 | $4.42 |
| Operating Cash Flow (9M) | $3,408 million (vs. $2,719 million in 9M 2007) | |||
| Total Debt | $7,036 million (as of Sept 30, 2008) | |||
| Cash & Marketable Securities | $3,619 million (as of Sept 30, 2008) | |||
| Net Debt | $3,417 million |
Material Changes vs. Prior Period
- Sales Growth: Worldwide sales increased 6.2% in Q3 and 8.2% for the nine months ended Sept 30, 2008. Local-currency sales grew 4.4% in Q3, driven by acquisitions (4.0 percentage points) and price increases, offset by a 0.2% decline in organic volume.
- Segment Performance:
- Safety, Security and Protection Services: Sales up 27.1% (Q3) and 23.7% (9M), heavily driven by the acquisition of Aearo Technologies.
- Display and Graphics: Sales declined 16.1% (Q3) and 12.8% (9M) due to a 34% drop in Optical Systems sales caused by intense price pressure and attachment rate declines in the LCD market.
- Health Care: Sales up 10.7% (Q3) and 11.9% (9M), led by dental and orthodontic products.
- Unusual Items:
- Q3 2008: Included a $41 million pre-tax gain on the sale of real estate in Italy and $49 million in pre-tax exit activity charges (severance and asset impairments).
- 9M 2008: Included a $23 million pre-tax loss on the sale of HighJump Software and $19 million in exit activity charges in Q2.
- Comparison to 2007: The prior year (9M 2007) included an $854 million pre-tax gain from the sale of businesses (primarily the European pharmaceuticals business), which significantly boosted 2007 margins.
Guidance, Outlook, and Risks
- Outlook: Management expects foreign currency translation to negatively impact sales by 3% to 4% in Q4 2008, a reversal from the positive impact seen in Q3. The company is in "cash preservation and build mode," slowing capital expenditures and reducing hiring in the U.S., Canada, Japan, and Western Europe.
- Capital Allocation: The company does not expect to be in the market for its stock in any meaningful way in the near term. Approximately $2.6 billion remains available under the $7.0 billion share repurchase authorization.
- Risks and Contingencies:
- Legal Proceedings: Significant exposure to respirator mask/asbestos litigation. Following the Aearo acquisition, 3M recorded a $35 million liability estimate for Aearo-related claims. Total accrued liabilities for respirator/asbestos claims are $126 million, with $200 million in insurance receivables.
- Environmental: Ongoing remediation and regulatory activities regarding perfluorooctanyl compounds (PFCs) in Minnesota and Alabama. Total environmental liabilities are $174 million ($33M remediation + $141M other).
- Investments: The company holds $4 million in auction rate securities (Level 3 assets) that have failed to auction. These have been written down from an original par value of $34 million, with $13 million in temporary impairments recorded in other comprehensive income.
Investor Verification Checklist
- Optical Systems Trajectory: Verify the stabilization of the Optical Systems business and the timeline for exiting the transition period (expected end of 2008/early 2009).
- Asbestos Liability Exposure: Monitor the $35 million Aearo-related liability estimate and the status of insurance coverage litigation, as actual costs could exceed reserves if claim volumes or costs rise.
- Currency Impact: Assess the impact of the projected 3-4% negative currency translation in Q4 on full-year sales and earnings guidance.
- Auction Rate Securities: Review the liquidity status of the $4 million remaining auction rate securities and potential for further write-downs if markets remain inactive.
- Capital Expenditures: Confirm the reduction in CapEx spending and its impact on long-term growth capacity versus short-term cash preservation.